Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

KIDS vs DBVT vs ALKS vs ATEC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
KIDS
OrthoPediatrics Corp.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$444M
5Y Perf.-61.9%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%
ATEC
Alphatec Holdings, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$1.17B
5Y Perf.+74.2%

KIDS vs DBVT vs ALKS vs ATEC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
KIDS logoKIDS
DBVT logoDBVT
ALKS logoALKS
ATEC logoATEC
IndustryMedical - DevicesBiotechnologyBiotechnologyMedical - Devices
Market Cap$444M$1712.35T$5.90B$1.17B
Revenue (TTM)$243M$0.00$1.56B$595M
Net Income (TTM)$-40M$-168M$153M$-125M
Gross Margin73.1%65.4%89.6%
Operating Margin-12.1%12.3%-9.6%
Forward P/E24.8x27.1x
Total Debt$100M$22M$70M$620M
Cash & Equiv.$20M$194M$1.12B$161M

KIDS vs DBVT vs ALKS vs ATECLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

KIDS
DBVT
ALKS
ATEC
StockMay 20May 26Return
OrthoPediatrics Cor… (KIDS)10038.1-61.9%
DBV Technologies S.… (DBVT)10041.2-58.8%
Alkermes plc (ALKS)100216.4+116.4%
Alphatec Holdings, … (ATEC)100174.2+74.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: KIDS vs DBVT vs ALKS vs ATEC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ALKS leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. DBV Technologies S.A. is the stronger pick specifically for recent price momentum and sentiment. ATEC also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
KIDS
OrthoPediatrics Corp.
The Secondary Option

KIDS lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the #2 pick in this set and the best alternative if momentum is your priority.

  • +110.4% vs ATEC's -37.8%
Best for: momentum
ALKS
Alkermes plc
The Income Pick

ALKS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 1.06
  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
  • Lower P/E (24.8x vs 27.1x)
Best for: income & stability and sleep-well-at-night
ATEC
Alphatec Holdings, Inc.
The Growth Play

ATEC is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 25.0%, EPS growth 15.0%, 3Y rev CAGR 29.6%
  • 225.4% 10Y total return vs ALKS's -11.0%
  • 25.0% revenue growth vs DBVT's -100.0%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthATEC logoATEC25.0% revenue growth vs DBVT's -100.0%
ValueALKS logoALKSLower P/E (24.8x vs 27.1x)
Quality / MarginsALKS logoALKS9.8% margin vs ATEC's -21.1%
Stability / SafetyALKS logoALKSBeta 1.06 vs KIDS's 1.41, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs ATEC's -37.8%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

KIDS vs DBVT vs ALKS vs ATEC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

KIDSOrthoPediatrics Corp.
FY 2025
Trauma and Deformity
70.4%$166M
Spine
27.9%$66M
Sports Medicine And Other
1.7%$4M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
ATECAlphatec Holdings, Inc.
FY 2025
Products And Services
100.0%$764M

KIDS vs DBVT vs ALKS vs ATEC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGATEC

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 4 of 6 comparable metrics.

ALKS and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to ATEC's -21.1%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricKIDS logoKIDSOrthoPediatrics C…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcATEC logoATECAlphatec Holdings…
RevenueTrailing 12 months$243M$0$1.6B$595M
EBITDAEarnings before interest/tax-$13M-$112M$212M$4M
Net IncomeAfter-tax profit-$40M-$168M$153M-$125M
Free Cash FlowCash after capex-$13M-$151M$392M$7M
Gross MarginGross profit ÷ Revenue+73.1%+65.4%+89.6%
Operating MarginEBIT ÷ Revenue-12.1%+12.3%-9.6%
Net MarginNet income ÷ Revenue-16.3%+9.8%-21.1%
FCF MarginFCF ÷ Revenue-5.2%+25.1%+1.2%
Rev. Growth (YoY)Latest quarter vs prior year+13.3%+28.2%-100.0%
EPS Growth (YoY)Latest quarter vs prior year+2.2%+91.5%-4.1%+37.1%
ALKS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ALKS leads this category, winning 2 of 5 comparable metrics.

On an enterprise value basis, ALKS's 17.3x EV/EBITDA is more attractive than ATEC's 3752.1x.

MetricKIDS logoKIDSOrthoPediatrics C…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcATEC logoATECAlphatec Holdings…
Market CapShares × price$444M$1712.35T$5.9B$1.2B
Enterprise ValueMkt cap + debt − cash$525M$1712.35T$4.9B$1.6B
Trailing P/EPrice ÷ TTM EPS-10.40x-0.76x24.76x-8.07x
Forward P/EPrice ÷ next-FY EPS est.27.09x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple17.25x3752.09x
Price / SalesMarket cap ÷ Revenue1.88x4.00x1.54x
Price / BookPrice ÷ Book value/share1.19x0.66x3.28x32.28x
Price / FCFMarket cap ÷ FCF12.28x422.56x
ALKS leads this category, winning 2 of 5 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 8 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-4 for ATEC. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ATEC's 17.21x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs DBVT's 4/9, reflecting strong financial health.

MetricKIDS logoKIDSOrthoPediatrics C…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcATEC logoATECAlphatec Holdings…
ROE (TTM)Return on equity-11.4%-130.2%+8.8%-4.4%
ROA (TTM)Return on assets-7.9%-89.0%+5.4%-15.8%
ROICReturn on invested capital-5.3%+18.9%-12.6%
ROCEReturn on capital employed-6.4%-145.7%+14.2%-13.7%
Piotroski ScoreFundamental quality 0–94476
Debt / EquityFinancial leverage0.29x0.13x0.04x17.21x
Net DebtTotal debt minus cash$80M-$172M-$1.0B$459M
Cash & Equiv.Liquid assets$20M$194M$1.1B$161M
Total DebtShort + long-term debt$100M$22M$70M$620M
Interest CoverageEBIT ÷ Interest expense-5.55x-189.82x32.30x-3.29x
ALKS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $2,738 for KIDS. Over the past 12 months, DBVT leads with a +110.4% total return vs ATEC's -37.8%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs KIDS's -27.6% — a key indicator of consistent wealth creation.

MetricKIDS logoKIDSOrthoPediatrics C…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcATEC logoATECAlphatec Holdings…
YTD ReturnYear-to-date+0.1%+4.9%+25.3%-62.7%
1-Year ReturnPast 12 months-20.8%+110.4%+16.5%-37.8%
3-Year ReturnCumulative with dividends-62.0%+19.7%+14.5%-47.8%
5-Year ReturnCumulative with dividends-72.6%-69.1%+60.9%-48.7%
10-Year ReturnCumulative with dividends-8.6%-87.0%-11.0%+225.4%
CAGR (3Y)Annualised 3-year return-27.6%+6.2%+4.6%-19.5%
DBVT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than KIDS's 1.41 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs ATEC's 33.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricKIDS logoKIDSOrthoPediatrics C…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcATEC logoATECAlphatec Holdings…
Beta (5Y)Sensitivity to S&P 5001.41x1.26x1.06x1.13x
52-Week HighHighest price in past year$23.70$26.18$36.60$23.29
52-Week LowLowest price in past year$14.42$7.53$25.17$6.85
% of 52W HighCurrent price vs 52-week peak+74.1%+76.3%+96.7%+33.3%
RSI (14)Momentum oscillator 0–10058.148.160.226.8
Avg Volume (50D)Average daily shares traded171K252K2.3M3.0M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

KIDS leads this category, winning 1 of 1 comparable metric.

Analyst consensus: KIDS as "Buy", DBVT as "Buy", ALKS as "Buy", ATEC as "Buy". Consensus price targets imply 222.6% upside for ATEC (target: $25) vs 19.5% for KIDS (target: $21).

MetricKIDS logoKIDSOrthoPediatrics C…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcATEC logoATECAlphatec Holdings…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$21.00$46.33$44.00$25.00
# AnalystsCovering analysts13152816
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises100
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%0.0%
KIDS leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). DBVT leads in 1 (Total Returns).

Best OverallAlkermes plc (ALKS)Leads 4 of 6 categories
Loading custom metrics...

KIDS vs DBVT vs ALKS vs ATEC: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is KIDS or DBVT or ALKS or ATEC a better buy right now?

For growth investors, Alphatec Holdings, Inc.

(ATEC) is the stronger pick with 25. 0% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate OrthoPediatrics Corp. (KIDS) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — KIDS or DBVT or ALKS or ATEC?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -72. 6% for OrthoPediatrics Corp. (KIDS). Over 10 years, the gap is even starker: ATEC returned +225. 4% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — KIDS or DBVT or ALKS or ATEC?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

06β versus OrthoPediatrics Corp. 's 1. 41β — meaning KIDS is approximately 33% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 17% for Alphatec Holdings, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — KIDS or DBVT or ALKS or ATEC?

By revenue growth (latest reported year), Alphatec Holdings, Inc.

(ATEC) is pulling ahead at 25. 0% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Alphatec Holdings, Inc. grew EPS 15. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ATEC leads at 29. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — KIDS or DBVT or ALKS or ATEC?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -18. 8% for Alphatec Holdings, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -12. 3% for KIDS. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is KIDS or DBVT or ALKS or ATEC more undervalued right now?

Analyst consensus price targets imply the most upside for ATEC: 222.

6% to $25. 00.

07

Which pays a better dividend — KIDS or DBVT or ALKS or ATEC?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is KIDS or DBVT or ALKS or ATEC better for a retirement portfolio?

For long-horizon retirement investors, Alphatec Holdings, Inc.

(ATEC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 13), +225. 4% 10Y return). Both have compounded well over 10 years (ATEC: +225. 4%, KIDS: -8. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between KIDS and DBVT and ALKS and ATEC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: KIDS is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; ATEC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

KIDS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Gross Margin > 43%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

ATEC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 53%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.